Description
Remacemide, also known as PR-934423 and FPL 12924AA, is a non-competitive NMDA receptor antagonist, which blocks ion channel and allosteric modulatory site (IC50 = 8-68 mM). Remacemide Hydrochloride has been used in pharmaceutical studies as a potential treatment to ischemic stroke, epilepsy, Parkinson's disease and Huntington's disease